Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Estimated societal costs of assertive community mental health care.

Wolff N, Helminiak TW, Diamond RJ.

Psychiatr Serv. 1995 Sep;46(9):898-906. Review.

PMID:
7583499
2.

The societal cost of schizophrenia in Sweden.

Ekman M, Granstrom O, Omerov S, Jacob J, Landen M.

J Ment Health Policy Econ. 2013 Mar;16(1):13-25.

PMID:
23676412
3.

Cost-effectiveness evaluation of three approaches to case management for homeless mentally ill clients.

Wolff N, Helminiak TW, Morse GA, Calsyn RJ, Klinkenberg WD, Trusty ML.

Am J Psychiatry. 1997 Mar;154(3):341-8.

PMID:
9054781
4.

Service costs of caring for adolescents with mental illness in a rural community, 1993-2000.

Costello EJ, Copeland W, Cowell A, Keeler G.

Am J Psychiatry. 2007 Jan;164(1):36-42.

PMID:
17202542
5.

Medicaid managed care and the distribution of societal costs for persons with severe mental illness.

Shern DL, Jones K, Chen HJ, Jordan N, Ramoni-Perazzi J, Boothroyd RA.

Am J Psychiatry. 2008 Feb;165(2):254-60. doi: 10.1176/appi.ajp.2007.06122089. Epub 2008 Jan 15.

PMID:
18198269
7.

Pursuing cost-effectiveness in mental health service delivery for youth with complex needs.

Grimes KE, Schulz MF, Cohen SA, Mullin BO, Lehar SE, Tien S.

J Ment Health Policy Econ. 2011 Jun;14(2):73-83.

PMID:
21881163
8.

Cost assessment of a school-based mental health screening and treatment program in New York City.

Chatterji P, Caffray CM, Crowe M, Freeman L, Jensen P.

Ment Health Serv Res. 2004 Sep;6(3):155-66.

PMID:
15473102
9.

Effect of full-service partnerships on homelessness, use and costs of mental health services, and quality of life among adults with serious mental illness.

Gilmer TP, Stefancic A, Ettner SL, Manning WG, Tsemberis S.

Arch Gen Psychiatry. 2010 Jun;67(6):645-52. doi: 10.1001/archgenpsychiatry.2010.56.

PMID:
20530014
10.

Cost of schizophrenia in England.

Mangalore R, Knapp M.

J Ment Health Policy Econ. 2007 Mar;10(1):23-41.

PMID:
17417045
11.

Costs and outcome of assertive community treatment (ACT) in a rural area in Denmark: 4-year register-based follow-up.

Hastrup LH, Aagaard J.

Nord J Psychiatry. 2015 Feb;69(2):110-7. doi: 10.3109/08039488.2014.936500. Epub 2014 Aug 18.

PMID:
25131794
12.

Variation in use and costs of primary health and social services in mental health or drinking problems.

Forma L, Jarvala T, Ahonen J, Vitikainen K, Rissanen P.

J Ment Health Policy Econ. 2009 Jun;12(2):79-86.

PMID:
19567933
13.

Cost-effectiveness of assertive community treatment for homeless persons with severe mental illness.

Lehman AF, Dixon L, Hoch JS, Deforge B, Kernan E, Frank R.

Br J Psychiatry. 1999 Apr;174:346-52.

PMID:
10533554
14.

Capitated assertive community treatment program savings: system implications.

Chandler D, Spicer G.

Adm Policy Ment Health. 2002 Sep;30(1):3-19.

PMID:
12546253
15.

Enrollment duration, service use, and costs of care for severely mentally ill members of a health maintenance organization.

McFarland BH, Johnson RE, Hornbrook MC.

Arch Gen Psychiatry. 1996 Oct;53(10):938-44.

PMID:
8857871
16.

WITHDRAWN: Assertive community treatment for people with severe mental disorders.

Marshall M, Lockwood A.

Cochrane Database Syst Rev. 2011 Apr 13;(4):CD001089. doi: 10.1002/14651858.CD001089.pub2. Review.

PMID:
21491382
17.

The difficult task of predicting the costs of community-based mental health care. A comprehensive case register study.

Donisi V, Jones J, Pertile R, Salazzari D, Grigoletti L, Tansella M, Amaddeo F.

Epidemiol Psychiatr Sci. 2011 Sep;20(3):245-56.

PMID:
21922967
18.

Use of Medicaid for mental health care by clients of community support programs.

Hollingsworth EJ.

Community Ment Health J. 1994 Dec;30(6):541-9.

PMID:
7835040
19.

The cost and outcomes of community-based care for the seriously mentally ill.

Dickey B, Fisher W, Siegel C, Altaffer F, Azeni H.

Health Serv Res. 1997 Dec;32(5):599-614.

20.

Cost of disorders of the brain in Europe 2010.

Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, Dodel R, Ekman M, Faravelli C, Fratiglioni L, Gannon B, Jones DH, Jennum P, Jordanova A, Jönsson L, Karampampa K, Knapp M, Kobelt G, Kurth T, Lieb R, Linde M, Ljungcrantz C, Maercker A, Melin B, Moscarelli M, Musayev A, Norwood F, Preisig M, Pugliatti M, Rehm J, Salvador-Carulla L, Schlehofer B, Simon R, Steinhausen HC, Stovner LJ, Vallat JM, Van den Bergh P, van Os J, Vos P, Xu W, Wittchen HU, Jönsson B, Olesen J; CDBE2010Study Group.

Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79. doi: 10.1016/j.euroneuro.2011.08.008. Epub 2011 Sep 15. Erratum in: Eur Neuropsychopharmacol. 2012 Mar;22(3):237-8. den Bergh, Peter Van [corrected to Van den Bergh, Peter].

PMID:
21924589

Supplemental Content

Support Center